MHRA-2022-0008-V108
Major variation for application MHRA-2022-0008. Major variation: New Dosage Strength for Pancrelipaze-R — major revision
Variation Number
MHRA-2022-0008-V108
Type
Major
Application
Change
Status
Blocked
Fee
€63,653
Submitted
—
Approved
—
Description
Major variation: New Dosage Strength for Pancrelipaze-R — major revision